|
Volumn 14, Issue 2, 2015, Pages 201-207
|
Interstitial 125I Seed Implantation for Cervical Lymph Node Recurrence after Multimodal Treatment of Thoracic Esophageal Squamous Cell Carcinoma
|
Author keywords
125I seed implantation; Cervical lymph node; Esophageal cancer
|
Indexed keywords
IODINE 125;
RADIOACTIVE IODINE;
RADIOPHARMACEUTICAL AGENT;
ADULT;
ARTICLE;
CERVICAL LYMPH NODE;
DISEASE COURSE;
DOSIMETRY;
ECHOGRAPHY;
ESOPHAGEAL SQUAMOUS CELL CARCINOMA;
EVALUATION AND FOLLOW UP;
FEMALE;
HUMAN;
IMPLANTATION;
LYMPH NODE DISSECTION;
MAJOR CLINICAL STUDY;
MALE;
MIDDLE AGED;
MULTIVARIATE ANALYSIS;
OVERALL SURVIVAL;
PERFORMANCE;
UNIVARIATE ANALYSIS;
AGED;
CARCINOMA, SQUAMOUS CELL;
ESOPHAGEAL NEOPLASMS;
LYMPH NODE METASTASIS;
MULTIMODALITY CANCER THERAPY;
NECK;
PATHOLOGY;
RETROSPECTIVE STUDY;
SECONDARY;
TREATMENT OUTCOME;
TUMOR RECURRENCE;
AGED;
CARCINOMA, SQUAMOUS CELL;
COMBINED MODALITY THERAPY;
ESOPHAGEAL NEOPLASMS;
FEMALE;
HUMANS;
IODINE RADIOISOTOPES;
LYMPHATIC METASTASIS;
MALE;
MIDDLE AGED;
NECK;
NEOPLASM RECURRENCE, LOCAL;
RADIOPHARMACEUTICALS;
RETROSPECTIVE STUDIES;
TREATMENT OUTCOME;
|
EID: 84940446795
PISSN: 15330346
EISSN: 15330338
Source Type: Journal
DOI: 10.7785/tcrt.2012.500409 Document Type: Article |
Times cited : (33)
|
References (0)
|